Literature DB >> 31162762

Efficacy of posttreatment radioiodine scanning in patients with differentiated thyroid cancer.

Shorook Na'ara1,2, Kamel Mahameed3, Moran Amit1,2, Jacob T Cohen1,2, Michal Weiler-Sagie4, Igor Albitskiy3, Ziv Gil1,2, Salem Billan2,3.   

Abstract

BACKGROUND: Differentiated thyroid cancers often require radioiodine treatment followed by posttreatment scan. We aimed in this study to assess the utility of the posttreatment radioiodine scan in this population.
METHODS: An analysis of patients who received radioiodine treatment at Rambam Campus, during 2006-2013. Scans showing remnant normal thyroid tissue were considered as normal. Positive uptake was defined as uptake in the lateral neck or distant sites.
RESULTS: A total of 455 patients were analyzed, 68% had T1-T2 and 28% had positive lymph nodes. Positive uptake in the lateral neck was recorded in 52 (11.4%) and in distant sites in 41 (9%) patients. Tracheal invasion, esophageal invasion, nerve invasion, and N1b classification were associated with a positive scan (P < .05). A positive radioactive iodine scan was not related to poor prognosis.
CONCLUSIONS: Posttreatment scans are positive in only 20% of patients. Locally invasive tumor and positive nodes are associated with positive scans.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; papillary carcinoma; radioiodine treatment; thyroid; whole-body scan

Mesh:

Substances:

Year:  2019        PMID: 31162762     DOI: 10.1002/hed.25833

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

Review 1.  UPDATED UNDERSTANDING OF THE MOLECULAR TARGETS OF RADIOIODINE IN DIFFERENTIATED THYROID CANCER.

Authors:  Y Zhang; W Zou; X Zhu; L Jiang; C Gui; Q Fan; Y Tu; J Chen
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

Review 2.  Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.

Authors:  Mohamed Aashiq; Deborah A Silverman; Shorook Na'ara; Hideaki Takahashi; Moran Amit
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

3.  Editorial: Does Every Thyroid Cancer Patient Need Surgery?

Authors:  Ziv Gil; Salem Billan
Journal:  Rambam Maimonides Med J       Date:  2022-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.